We are monitoring the impact of COVID-19 on Europe Infectious Disease Therapeutics Market Get in touch with us for detailed analysis Know More
Pulished Date February, 2020
ID: 1247
Share on
Share on

Europe Infectious Disease Therapeutics Market Research Report – Segmented By Mode Of Treatment, Target Organism, Infection Type, Distribution Channels and Country (United Kingdom, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands and Rest of Europe) - Industry Analysis, Size, Share, Trends & Growth Forecast (2020 to 2025)

Pulished: February, 2020
ID: 1247
Pages: 145

Europe Infectious Disease Therapeutics Market Size (2020 to 2025)

The size of the Europe Infectious Disease Therapeutics Market was worth USD 27.33 Billion in 2020 and estimated to reach USD 38.3 Billion by the end of 2025, growing at a CAGR of 6.98% between 2020 to 2025.

Infectious diseases are caused by pathogens such as bacteria, viruses, parasites, fungi. These diseases will spread, directly or indirectly, from one person to another person. So, anti-infective drugs are used to prevent the growth of such diseases. These drugs directly target the causative agent and hinder the growth of the disease. Infectious diseases such as malaria, HIV, tuberculosis, influenza, and salmonella pose a major challenge.

Some of the major factors driving the European infectious disease Market are the increasing occurrence of infectious diseases, increasing health care expenditure and increasing geriatric population, growing healthcare awareness, and increasing government funding in developing countries. Generic erosion, Patent expiration of infectious disease drugs are the factors that hinder the growth of the market.

This research report on the European Infectious Disease Therapeutics Market has been segmented & sub-segmented into the following categories:

By Mode of Treatment:

  • Drugs     
  • Vaccines    

By Target Organism:

  • Antibacterial      
  • Antifungal
  • Antiviral  
  • Antiparasite      
  • others     

By Infection type: 

  • Bacterial  
  • Viral      
  • Fungal    
  • Parasitic  
  • Others    

By Distribution Channels: 

  • Hospitals  
  • Clinics     
  • Others

By Country:

  • United Kingdom
  • France
  • Spain
  • Germany
  • Italy
  • Russia
  • Sweden
  • Denmark
  • Switzerland
  • Netherlands
  • Rest of Europe

Companies that are playing an influential role in the European Infectious disease Therapeutics Market profiled in this report are F. Hoffmann-La Roche, Gilead Sciences, GlaxoSmithKline, Johnson & Johnson, Merck & Co, Pfizer, Achillion Pharmaceuticals, Novartis, AbbVie, Astellas Pharma, AstraZeneca, Auritec Pharmaceuticals, Bayer, Bristol-Myers Squibb, Chimerix Pharmaceuticals, Cubist, Eli Lilly, Isis Pharmaceuticals, Mitsubishi Tanabe Pharma, pSivida, Sanofi.

1.Introduction                                  

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                           

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                              

                2.2 Research Phases                      

                                2.2.1 Secondary Research            

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling     

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                      

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                             

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                      

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market               

5. Market Segmentation                                              

                5.1 Mode of Treatment                

                                5.1.1 Introduction           

                                5.1.2 Drugs        

                                                5.1.2.1 Oral Administration

                                                5.1.2.2 Topical

                                                5.1.2.3 Injections

                                                5.1.2.4 Others

                                5.1.3 Vaccines  

                                5.1.4 Y-o-Y Growth Analysis, By Mode of treatment         

                                5.1.5 Market Attractiveness Analysis, By Mode of treatment        

                                5.1.6 Market Share Analysis, By Mode of treatment         

                5.2 Target Organism                      

                                5.2.1 Introduction           

                                5.2.2 Antibacterial          

                                5.2.3 Antifungal

                                5.2.4 Antiviral   

                                5.2.5 Antiparasite           

                                5.2.6 others       

                                5.2.7 Y-o-Y Growth Analysis, By Target Organism               

                                5.2.8 Market Attractiveness Analysis, By Target Organism             

                                5.2.9 Market Share Analysis, By Target Organism              

                5.3 Infection type                           

                                5.3.1 Introduction           

                                5.3.2 Bacterial   

                                5.3.3 Viral           

                                5.3.4 Fungal       

                                5.3.5 parasitic   

                                5.3.6 others       

                                5.3.7 Y-o-Y Growth Analysis, By Infection type    

                                5.3.8 Market Attractiveness Analysis, By Infection type  

                                5.3.9 Market Share Analysis, By Infection Type   

                5.4 Distribution Channels                            

                                5.4.1 Hospitals  

                                5.4.2 Clinics        

                                5.4.3 Others      

                                5.4.4 Y-o-Y Growth Analysis, By Distribution Channels     

                                5.4.5 Market Attractiveness Analysis, By Distribution Channels   

                                5.4.6 Market Share Analysis, By Distribution Channels    

6. Geographical Analysis                                              

                6.1 Introduction                              

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By Mode of Treatment

                                                6.1.3.3 By Target organism

                                                6.1.3.4 By Infection Type

                                                6.1.3.5 By Distribution Channels

                                6.1.4 Market Attractiveness Analysis      

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Mode of Treatment

                                                6.1.4.3 By Target organism

                                                6.1.4.4 By Infection Type

                                                6.1.4.5 By Distribution Channels

                                6.1.5 Market Share Analysis        

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Mode of Treatment

                                                6.1.5.3 By Target organism

                                                6.1.5.4 By Infection Type

                                                6.1.5.5 By Distribution Channels

                6.2 U.K                

                6.3 Spain                             

                6.4 Germany                     

                6.5 Italy                               

                6.6 France                          

7.Strategic Analysis                                        

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental      

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services

                                7.2.5 Competitive Rivalry within the Industry      

8.Market Leaders' Analysis                                          

                8.1 F. Hoffmann-La Roche                           

                                8.1.1 Overview

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 Gilead Sciences                         

                8.3 GlaxoSmithKline                      

                8.4 Johnson & Johnson                 

                8.5 Merck & Co                

                8.6 Pfizer                            

                8.7 Achillion Pharmaceuticals                    

                8.8 Novartis                       

                8.9 Abbvie                         

                8.10 Astellas Pharma                     

                8.11 AstraZeneca                            

                8.12 Auritec Pharmaceuticals                     

                8.13 Bayer                          

                8.14 Bristol-Myers Squibb                           

                8.15 Chimerix Pharmaceuticals                 

                8.16 Cubist                         

                8.17 Eli Lilly                        

                8.18 Isis Pharmaceuticals                             

                8.19 pSivida                       

                8.20 Sanofi                         

9.Competitive Landscape                                            

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                        

                9.3 Agreements, collaborations and Joint Ventures                          

                9.4 New Product Launches                          

10.Market Outlook and Investment Opportunities                                           

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Europe Infectious Disease Therapeutics Market, By Mode of treatment, From 2020 to 2025 (USD Billion)
  2. Europe Drugs Market, By Region, From 2020 to 2025 (USD Billion)
  3. Europe vaccines Market, By Region, From 2020 to 2025 (USD Billion)
  4. Europe Infectious Disease Therapeutics Market, By Target Organism, From 2020 to 2025 (USD Billion)
  5. Europe Antibacterial Market, By Region, From 2020 to 2025 (USD Billion)
  6. Europe Antifungal Market, By Region, From 2020 to 2025 (USD Billion)
  7. Europe Antiviral Market, By Region, From 2020 to 2025 (USD Billion)
  8. Europe Antiparasite Market, By Region, From 2020 to 2025 (USD Billion)
  9. Europe Infectious Disease Therapeutics Market, By Infection Type, From 2020 to 2025 (USD Billion)
  10. Europe Bacterial Market, By Region, From 2020 to 2025 (USD Billion)
  11. Europe Viral Market, By Region, From 2020 to 2025 (USD Billion)
  12. Europe Fungal Market, By Region, From 2020 to 2025 (USD Billion)
  13. Europe Parasitic Market, By Region, From 2020 to 2025 (USD Billion)
  14. Europe Infectious Disease Therapeutics Market, By Distribution Channels, From 2020 to 2025 (USD Billion)
  15. Europe Hospitals Market, By Region, From 2020 to 2025 (USD Billion)
  16. Europe Clinics Market, By Region, From 2020 to 2025 (USD Billion)
  17. U.K. Infectious Disease Therapeutics Market, By Mode of treatment, From 2020 to 2025 (USD Billion)
  18. U.K. Infectious Disease Therapeutics Market, By Target Organism, From 2020 to 2025 (USD Billion)
  19. U.K. Infectious Disease Therapeutics Market, By Infection Type, From 2020 to 2025 (USD Billion)
  20. U.K. Infectious Disease Therapeutics Market, By Distribution Channels, From 2020 to 2025 (USD Billion)
  21. Germany Infectious Disease Therapeutics Market, By Mode of treatment, From 2020 to 2025 (USD Billion)
  22. Germany Infectious Disease Therapeutics Market, By Target Organism, From 2020 to 2025 (USD Billion)
  23. Germany Infectious Disease Therapeutics Market, By Infection Type, From 2020 to 2025 (USD Billion)
  24. Germany Infectious Disease Therapeutics Market, By Distribution Channels, From 2020 to 2025 (USD Billion)
  25. France Infectious Disease Therapeutics Market, By Mode of treatment, From 2020 to 2025 (USD Billion)
  26. France Infectious Disease Therapeutics Market, By Target Organism, From 2020 to 2025 (USD Billion)
  27. France Infectious Disease Therapeutics Market, By Infection Type, From 2020 to 2025 (USD Billion)
  28. France Infectious Disease Therapeutics Market, By Distribution Channels, From 2020 to 2025 (USD Billion)
  29. Italy Infectious Disease Therapeutics Market, By Mode of treatment, From 2020 to 2025 (USD Billion)
  30. Italy Infectious Disease Therapeutics Market, By Target Organism, From 2020 to 2025 (USD Billion)
  31. Italy Infectious Disease Therapeutics Market, By Infection Type, From 2020 to 2025 (USD Billion)
  32. Italy Infectious Disease Therapeutics Market, By Distribution Channels, From 2020 to 2025 (USD Billion)
  33. Spain Infectious Disease Therapeutics Market, By Mode of treatment, From 2020 to 2025 (USD Billion)
  34. Spain Infectious Disease Therapeutics Market, By Target Organism, From 2020 to 2025 (USD Billion)
  35. Spain Infectious Disease Therapeutics Market, By Infection Type, From 2020 to 2025 (USD Billion)
  36. Spain Infectious Disease Therapeutics Market, By Distribution Channels, From 2020 to 2025 (USD Billion)
  37. Europe Infectious disease Therapeutics Market, By Drugs, From 2020 to 2025 (USD Billion)
  38. Europe Oral Administration Market, By Region, From 2020 to 2025 (USD Billion)
  39. Europe Topical Market, By Region, From 2020 to 2025 (USD Billion)
  40. Europe Injections Market, By Region, From 2020 to 2025 (USD Billion)
  41. U.K. Infectious disease Therapeutics Market, By Drugs, From 2020 to 2025 (USD Billion)
  42. Germany Infectious disease Therapeutics Market, By Drugs, From 2020 to 2025 (USD Billion)
  43. France Infectious disease Therapeutics Market, By Drugs, From 2020 to 2025 (USD Billion)
  44. Italy Infectious disease Therapeutics Market, By Drugs, From 2020 to 2025 (USD Billion)
  45. Spain Infectious disease Therapeutics Market, By Drugs, From 2020 to 2025 (USD Billion)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample